政在发声｜医药工业数智化转型“蓝图”：重构产业生态，千亿市场新增长极有待激活

MoFo partner Chuan Sun has been quoted in a recent article on the digital transformation of China's pharmaceutical industry.

Chuan has advised on a transaction involving AI-driven pharmaceutical. “From investors' perspective, industry experts are increasingly focusing on the practical applications of AI, particularly in the life sciences field, such as drug discovery and clinical trial design. The demand for such applications is extremely widespread, and the emergence of DeepSeek is expected to drive the widespread adoption of these applications. For startups, DeepSeek may become an industry benchmark for some time. In the early stages, it may symbolize a company's capabilities, but over time, once startups can integrate advanced models like DeepSeek into their systems at a lower cost and begin executing related tasks, this will be similar to the widespread adoption of cloud computing and ERP systems a few years ago, significantly enhancing operational efficiency,” Chuan said.

Read the full article.